Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286749 · ClinicalTrials.gov registry record · NA
Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT05286749: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT05286749 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05286749, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether educational workshops paired with self-collected high-risk human papillomaviruses (hrHPV) screening will increase participation in cervical cancer screening among Southeast Asian Immigrant and Refugee populations in Wisconsin compared with offering clinician collected screening (total sample size: 250 participants). The investigators hypothesize that participation in cervical cancer screening will be higher among women in the intervention group as compared to the control group.
Primary Outcome
The results will be reported through summary statistics of the number of participants in each group subsequently engaging or seeking out cervical cancer screening either through services offered after workshop education or self-reported desire to follow up through their community health care provider.
Interventions
- PROCEDURE Workshop plus Clinician-Collected Cervical Swab
- DEVICE Workshop plus Participant-Collected Cervical Swab
- DIAGNOSTIC_TEST HPV testing on Participant-Collected Cervical Swab Samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2022-08-13 |
| Est. Completion | 2024-02-10 |
| Phase | NA |
What the finished NCT05286749 record still lists
NCT05286749 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Workshop plus Clinician-Collected Cervical Swab is the first listed.
NCT05286749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05286749 about?
NCT05286749 is a clinical study titled "Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women". The primary purpose of this study is to determine whether educational workshops paired with self-collected high-risk human papillomaviruses (hrHPV) screening will increase participation in cervical cancer screening among Southeast Asian Immigrant and Refugee populations in Wisconsin compared with of...
What is the current status of trial NCT05286749?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2022-08-13. Estimated completion is 2024-02-10.
What interventions are being tested in trial NCT05286749?
The interventions under investigation include: Workshop plus Clinician-Collected Cervical Swab (PROCEDURE), Workshop plus Participant-Collected Cervical Swab (DEVICE), HPV testing on Participant-Collected Cervical Swab Samples (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05286749?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05286749's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI